ViroSure

ViroSure

Vienna, Austria· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ViruSure is a specialized biosafety testing CRO serving global biopharma and advanced therapy clients from its Vienna, Austria base. Founded in 2010, the company offers a comprehensive suite of GLP/GMP-compliant services including virus clearance studies, in vitro/in vivo safety testing, cell and virus banking, and regulatory consultancy. Its business model is purely service-based, positioning it as a critical partner for companies developing biologics, vaccines, cell and gene therapies, and even cell-cultured meat, ensuring regulatory compliance and product safety.

DiagnosticsInfectious Disease

Technology Platform

Integrated suite of GLP/GMP biosafety testing methodologies including virus clearance studies, in vitro/in vivo adventitious agent testing, molecular assays (PCR, NGS), cell & virus banking, and regulatory consultancy.

Opportunities

Significant growth is driven by the expanding cell and gene therapy (ATMP) market and the emergence of the cell-cultured meat industry, both requiring novel biosafety testing frameworks.
Increased outsourcing by biopharma companies and continuous regulatory stringency ensure sustained demand for specialized CRO services.

Risk Factors

Revenue is tied to biopharma R&D spending, making it vulnerable to industry downturns.
The competitive CRO landscape and the constant need to adapt to evolving regulatory guidelines pose significant operational and business risks.
Reputational damage from any testing failure could be severe.

Competitive Landscape

ViruSure competes in the specialized biosafety testing CRO market against large, full-service global CROs (e.g., LabCorp, Charles River Labs) and other niche players. Its differentiation is its deep focus on virus safety, expertise in advanced therapies, and strong European regulatory foundation, competing on quality and specialization rather than scale alone.